Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRelay Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2024 | 2 | -$0.73 | -$0.73 | -$0.73 |
| Q3 2024 | 3 | -$0.77 | -$0.77 | -$0.77 |
| Q4 2024 | 8 | -$0.69 | -$0.38 | -$0.57 |
| Q1 2025 | 5 | -$0.67 | -$0.53 | -$0.60 |
| Q2 2025 | 4 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2025 | 4 | -$0.64 | -$0.64 | -$0.64 |
| Q4 2025 | 4 | -$0.64 | -$0.64 | -$0.64 |
Relay Therapeutics, Inc. Earnings Date And Information
Relay Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.63 earnings per share for the quarter, topping analysts' consensus estimates of $-0.77 by $0.14. The company had revenue of 0 for the quarter and had revenue of 25.55 M for the year. Relay Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.79 diluted earnings per share) and currently has a price-to-earnings ratio of -1.74. Relay Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Relay Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.77 | -$0.63 | 0.14 | $88,889 | $0 |
| 08/06/2024 | Q2 2024 | -$0.73 | -$0.69 | 0.04 | $88,889 | $0 |
| 05/02/2024 | Q1 2024 | -$0.70 | -$0.62 | 0.08 | $10.01 M | |
| 02/22/2024 | Q4 2023 | -$0.76 | -$0.68 | 0.08 | $-1,000 | |
| 11/02/2023 | Q3 2023 | -$0.83 | -$0.54 | 0.29 | $374,545 | $25.20 M |
| 08/08/2023 | Q2 2023 | -$0.78 | -$0.81 | -0.03 | $741,667 | $119,000 |
| 05/04/2023 | Q1 2023 | -$0.70 | -$0.72 | -0.02 | $226,000 | |
| 02/23/2023 | Q4 2022 | -$0.71 | -$0.36 | 0.35 | $253,000 | |
| 11/03/2022 | Q3 2022 | -$0.71 | -$0.79 | -0.08 | $1.80 M | $344,000 |
| 08/04/2022 | Q2 2022 | -$0.62 | -$0.71 | -0.09 | $2.08 M | $365,000 |
| 05/05/2022 | Q1 2022 | -$0.63 | -$0.48 | 0.15 | $419,000 | |
| 02/24/2022 | Q4 2021 | -$0.60 | -$0.66 | -0.06 | $567,000 | |
| 11/10/2021 | Q3 2021 | -$0.65 | -$0.66 | -0.01 | $107,143 | $666,000 |
| 08/12/2021 | Q2 2021 | -$0.48 | -$2.10 | -1.62 | $6.67 M | $844,000 |
| 05/13/2021 | Q1 2021 | -$0.48 | -$0.47 | 0.01 | $952,000 | |
| 03/25/2021 | Q4 2020 | $0.17 | $0.50 | 0.33 | $82.65 M | |
| 11/12/2020 | Q3 2020 | -$0.35 | -$0.51 | -0.16 | $0 | |
| 08/27/2020 | Q2 2020 | -$0.66 | -$6.06 | -5.4 | $0 | |
| 03/30/2020 | Q1 2020 | -$5.99 | $0 | |||
| 12/30/2019 | Q4 2019 | -$6.24 | $0 |
Relay Therapeutics, Inc. Earnings: FAQ's
When is Relay Therapeutics, Inc.'s earnings date?
Relay Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
Did Relay Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Relay Therapeutics, Inc. (:RLAY) reported $-0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.77 by $0.14.
How can I listen to Relay Therapeutics, Inc.'s earnings conference
call?
The conference call for Relay Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Relay Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Relay Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Relay Therapeutics, Inc. generate each year?
Relay Therapeutics, Inc. (:RLAY) has a recorded annual revenue of $25.55 M.
How much profit does Relay Therapeutics, Inc. generate each year?
Relay Therapeutics, Inc. (:RLAY) has a recorded net income of $25.55 M. Relay Therapeutics, Inc. has generated $-2.79 earnings per share over the last four quarters.
What is Relay Therapeutics, Inc.'s price-to-earnings ratio?
Relay Therapeutics, Inc. (:RLAY) has a price-to-earnings ratio of -1.74 and price/earnings-to-growth ratio is 0.49.